Professor Russell Katz, one of the FDA leaders, noted that for the health of the unborn child, a potential risk of dangerous consequences is many times higher than the alleged positive consequences after taking drugs, which include Valproat.
Professor Russell Katz, one of the FDA leaders, noted that for the health of the unborn child, a potential risk of dangerous consequences is many times higher than the alleged positive consequences after taking drugs, which include Valproat.